Multiple myeloma

Collins, Conor D

doi:10.1102/1470-7330.2004.0010

Cited by 52 publications

(34 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Radiographic findings at the time of presentation are common in patients with multiple myeloma 39 . The typical myeloma lesion is a "punched-out" radiolucent lesion, with a sharp zone of transition and an absence of surrounding reactive bone (Fig.…”

Section: Malignant Conditionsmentioning

confidence: 99%

See 1 more Smart Citation

The Evaluation and Treatment of Polyostotic Lesions

et al. 2014

View full text Add to dashboard Cite

Section: Malignant Conditionsmentioning

confidence: 99%

“…The typical myeloma lesion is a "punched-out" radiolucent lesion, with a sharp zone of transition and an absence of surrounding reactive bone (Fig. 7) 39 . Metastatic lesions are also usually lytic and similar in appearance to those of multiple myeloma.…”

Section: Malignant Conditionsmentioning

confidence: 99%

The Evaluation and Treatment of Polyostotic Lesions

et al. 2014

View full text Add to dashboard Cite

“…Almost 80% of patients with MM will have radiological evidence of skeletal involvement on the skeletal survey (11), however, the false-negative rate with skeletal surveys is relatively high (30–70%), leading to a significant underestimation of MM.…”

Section: Morphologic Imagingmentioning

confidence: 99%

Molecular Imaging in Myeloma Precursor Disease

Mena

Choyke

Tan

et al. 2011

Seminars in Hematology

View full text Add to dashboard Cite

Multiple myeloma (MM) is consistently preceded by its pre-malignant states, monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering multiple myeloma (SMM). By definition, precursor conditions do not exhibit end-organ disease (anemia, hypercalcemia, renal failure, skeletal lytic lesions, or a combination of these). However, new imaging methods are demonstrating that some patients in the MGUS or SNM category are exhibiting early signs of MM. Although MGUS/SMM patients are currently defined as low-risk versus high-risk based on clinical markers, we currently lack the ability to predict the individual patient’s risk of progression from MGUS/SMM to MM. Given that the presence of gross lytic bone lesions is a hallmark of MM, it is reasonable to believe that less severe bone changes defined by more sensitive imaging may be predictive of MM progression. Indeed, since bone disease is such an essential aspect of MM, imaging techniques directed at the detection of early bone lesions, have the potential to become increasingly more useful in the setting of MGUS/SMM. Current guidelines for the radiological assessment of MM still recommend the traditional skeletal survey, although its limitations are well-documented, especially in early phases of the disease when radiographs can significantly underestimate the extent of bone lesions and bone marrow involvement. Newer, more advanced imaging modalities, with higher sensitivities, including whole-body low-dose computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) are being employed. Also various imaging techniques have been used to provide an assessment of bone involvement and identify extra-osseous disease. This review emphasizes the current state of the art and emerging imaging methods, which may help to better define high-risk versus low-risk MGUS/SMM. Ultimately, improved imaging could allow more tailored clinical management, and, most likely play an important role in the development of future treatment strategies for high-risk precursor disease.

show abstract

“…The imaging patterns in multiple myeloma can be classified as normal, focal, diffuse and variegated [55, 56]. A more detailed discussion on the MRI patterns is presented elsewhere [57]. The lack of specificity of the MRI patterns should be noted.…”

Section: Anatomical Imagingmentioning

confidence: 99%